Related Experiment Video
Updated: Apr 7, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Neonatal Cholestasis Caused by Undiagnosed Maternal Graves' Disease
Raghu U Varier1, M Kyle Jensen2, Christa J Adams2
1University of Utah School of Medicine, Salt Lake City, UT ; Northwest Pediatric Gastroenterology, LLC, Portland, OR.
Insights
Hyperthyroidism is rarely linked to neonatal cholestasis. This case highlights a hyperthyroid infant with cholestasis whose newborn screening missed the thyroid dysfunction, emphasizing the need for careful evaluation.
Area of Science:
- Neonatology
- Endocrinology
- Pediatric Gastroenterology
Background:
- Neonatal cholestasis stems from diverse causes like anatomical, infectious, and metabolic issues.
- Hyperthyroidism is an uncommon cause of neonatal cholestasis, unlike hypothyroidism.
- Newborn screening aids in detecting metabolic disorders, including thyroid dysfunction.
Observation:
- A unique case of cholestasis in a neonate with hyperthyroidism is presented.
- The infant's mother had undiagnosed and untreated Graves' disease.
- The infant's metabolic screening did not identify the thyroid dysfunction.
Findings:
- Low or undetectable thyroid-stimulating hormone (TSH) levels may not be flagged as abnormal in newborn screenings.
- Hyperthyroidism, even in the context of maternal Graves' disease, can present with neonatal cholestasis.
- Standard newborn metabolic screens may not detect subclinical or overt hyperthyroidism contributing to cholestasis.
Implications:
- Clinicians should consider hyperthyroidism in neonates with cholestasis, even with normal newborn screening results.
- Maternal thyroid status is crucial in evaluating neonatal cholestasis.
- Diagnostic criteria for newborn screening may need refinement to include low TSH levels for early detection of thyroid dysfunction.
Abstract:
Neonatal cholestasis results from a variety of etiologies, including anatomic, infectious, and metabolic abnormalities. Hyperthyroidism, in contrast to hypothyroidism, is infrequently associated with neonatal cholestasis. Newborn screening is an important tool to detect newborn metabolic disorders, including thyroid dysfunction. However, one must exercise caution when interpreting these reports; typically only high thyroid stimulating hormone (TSH) levels are flagged as abnormal, while low or undetectable levels may not be. We present a unique case of cholestasis in a hyperthyroid neonate of an untreated, undiagnosed mother with Graves' disease; the infant's metabolic screen was not flagged as abnormal.
More Related Videos
Related Concept Videos
Inborn Errors of Metabolism
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Acute Pancreatitis II: Clinical Manifestations and Management

